- CRS Publications
- News
News
Authors:
Date:
Business Wire: March 15, 2017 – BEDFORD, MA, U.S.A. – Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative therapies for diseases and conditions of the eye, today announced positive results of a patient…
Authors:
Date:
PRNewswire: March 14, 2017 – MOUNT OLIVE, NJ, U.S.A. – Flowonix Medical Inc. of New Jersey and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra® II programmable infusion system in the Australian Direct Drug Administration for Refractory Epilepsy (…
Authors:
Date:
PRNewswire: March 14, 2017 – SAN DIEGO, CA, U.S.A. – OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that they have entered into a technology access program (TAP) agreement with Inhibrx, LP, a privately…
Authors:
Date:
PRNewswire: March 14, 2017 – LUND, Sweden – Bonesupport AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease, or related surgery, announces that it has extended the term of its U.S. distribution agreement with Zimmer…
Authors:
Date:
Business Wire: March 14, 2017 – BOSTON, MA, U.S.A., and MUMBAI, India – TA Associates, a leading global growth private equity firm, today announced it has completed an investment in Ideal Cures Private Limited, a supplier of ready-to-use coating products and excipients for tablets and capsules to…
Authors:
Date:
Business Wire: March 3, 2017 – SEATTLE, WA, U.S.A. – Impel NeuroPharma, a Seattle-based clinical-stage biotechnology company developing first-in-class intranasal drug treatments, announced today the appointment of Timothy S. Nelson as independent director of the board of directors.
Mr. Nelson has…
